MTA2 and hepatocellular carcinoma: Guan et al. revealed that high expression levels of MTA2 were closely associated with advanced pathological stages and low overall survival of patients, and that MTA2 promoted HCC proliferation and metastasis in vitro and in vivo by inhibiting the Hippo signaling pathway [48].